Skip to main content
Veterinary Medicines

Lachesis/Argentum comp. PlantaVet

Authorised
  • LACHESIS D11
  • Hepar sulfuris D11
  • ARGENTUM METALLICUM DIL. D29 AQUOS.
  • ATROPA BELLADONNA EX HERBA FERM 33A DIL. D14 (HAB, VS. 33A)
  • Quarz D29
  • Mercurialis perennis ferm 34c D5

Product identification

Medicine name:
Lachesis/Argentum comp. PlantaVet
Active substance:
  • LACHESIS D11
  • Hepar sulfuris D11
  • ARGENTUM METALLICUM DIL. D29 AQUOS.
  • ATROPA BELLADONNA EX HERBA FERM 33A DIL. D14 (HAB, VS. 33A)
  • Quarz D29
  • Mercurialis perennis ferm 34c D5
Target species:
  • Dog
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • LACHESIS D11
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Hepar sulfuris D11
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • ARGENTUM METALLICUM DIL. D29 AQUOS.
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • ATROPA BELLADONNA EX HERBA FERM 33A DIL. D14 (HAB, VS. 33A)
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Quarz D29
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Mercurialis perennis ferm 34c D5
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
    • Cat
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Saluvet GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Wala-Heilmittel GmbH
  • Wala-Heilmittel GmbH
Responsible authority:
  • BVL
Authorisation number:
  • 6443053.00.00
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."